ADAM9 and lung cancer: Here we demonstrated that ADAM9 could inhibit the expression of miR-218 and that miR-218 can directly bind to the 3′-UTR of CDCP1. Down-regulation of miR-218 led to CDCP1 overexpression, which promoted malignancy of lung cancer cells.